IQ Consortium
Organization of pharmaceutical and biotechnology companies with a mission of advancing science and technology.
Under Construction
Check back soon for more IQ publications.
Recovery Animals in Toxicology Studies: An Innovation and Quality Consortium Perspective on Best Practices with Case Study Examples
International Journal of Toxicology, 2024
Salian-Mehta et al.
3Rs TPS LG
https://journals.sagepub.com/doi/abs/10.1177/10915818241243350
Science- and Risk-Based Stability Strategies to Support Product Lifecycle Changes
The AAPS Journal, 2024
McCaig et al.
ALG
The AAPS Journal, 26(2), 34. https://doi.org/10.1208/s12248-024-00903-z
Industry’s perspective on challenges assessing the in vivo impact of removing titanium dioxide (TiO2) from drug product
Journal of Pharmaceutical Sciences, 2024
Abend et al.
ALG, DPLG
Journal of Pharmaceutical Sciences, 113(11), 3119-3122.
https://www.sciencedirect.com/science/article/pii/S0022354924003034
Evaluating Clinical Safety and Analytical Impact of Subvisible Silicone Oil Particles in Biopharmaceutical Products
Journal of Pharmaceutical Sciences, 2024
Saggu et al.
BIO LG
Journal of Pharmaceutical Sciences. 2024 Jan 12:S0022-3549(24)00007-8
https://doi.org/10.1016/j.xphs.2024.01.002
Patient-centric Comparability Assessment of Biopharmaceuticals
Journal of Pharmaceutical Sciences, 2024
Blümel et al.
BIO LG
Journal of Pharmaceutical Sciences 113(6), 1415-1425
https://doi.org/10.1016/j.xphs.2024.02.010
Recommended Dose Volumes for Common Laboratory Animals
IQ Consortium, 2016
Contract Research Organization Working Group
IQ 3Rs Leadership Group
To read the article, click here.
